These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6090273)

  • 21. Toxicology and carcinogenesis studies of androstenedione (CAS No. 63-05-8) in F344/N rats and B6C3F1 mice (gavage studies).
    Natl Toxicol Program Tech Rep Ser; 2010 Sep; (560):1, 7-31,33-171 passim. PubMed ID: 21037592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
    Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
    Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of immunological parameters during tumour development in a murine model.
    Suresh K; Nirmala K; Kuruvilla K; Vasudevan DM
    Indian J Exp Biol; 1989 Jun; 27(6):497-501. PubMed ID: 2583740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice.
    Yang Z; Wu D; Zhou D; Jiao F; Yang W; Huan Y
    Cell Immunol; 2015 Jan; 293(1):17-21. PubMed ID: 25461613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
    National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,
    Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA; Walker MC; Phillips-Quagliata JM
    Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a murine lymphoma model system for the characterization of natural killer:tumor cell interactions.
    Smithson G; Wolcott RM; Chervenak R
    Cancer Res; 1992 Aug; 52(15):4149-56. PubMed ID: 1638530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 384():1-348. PubMed ID: 12692652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice.
    Sun T; Kim TS; Waltz MR; Cohen EP
    Cancer Gene Ther; 1995 Sep; 2(3):183-90. PubMed ID: 8528961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged survival of human hepatocarcinoma cells in the liver of newborn C57BL/6 mice and resulting cellular xenorejection, especially the activation of hepatic natural killer T cells.
    Du X; Bai Z; Zhang J; Liu L; Han Y; Wang Z; Huan T; Wu B
    Pathobiology; 2010; 77(3):115-28. PubMed ID: 20516727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-associated decline in precursor frequency for different T cell-mediated reactions, with preservation of helper or cytotoxic effect per precursor cell.
    Miller RA
    J Immunol; 1984 Jan; 132(1):63-8. PubMed ID: 6228584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
    Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
    Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental enrichment improves age-related immune system impairment: long-term exposure since adulthood increases life span in mice.
    Arranz L; De Castro NM; Baeza I; Maté I; Viveros MP; De la Fuente M
    Rejuvenation Res; 2010 Aug; 13(4):415-28. PubMed ID: 20707722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
    Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
    Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractalkine mediates natural killer-dependent antitumor responses in vivo.
    Lavergne E; Combadière B; Bonduelle O; Iga M; Gao JL; Maho M; Boissonnas A; Murphy PM; Debré P; Combadière C
    Cancer Res; 2003 Nov; 63(21):7468-74. PubMed ID: 14612547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
    Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
    J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cells inhibit the development of autoantibody production in (C57BL/6 x DBA/2) F1 hybrid mice injected with DBA/2 spleen cells.
    Harada M; Lin T; Kurosawa S; Maeda T; Umesue M; Itoh O; Matsuzaki G; Nomoto K
    Cell Immunol; 1995 Mar; 161(1):42-9. PubMed ID: 7867084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related decline in cell-mediated immunity in the C58 leukemic mouse strain.
    Bocchieri MH; Sabol JL; O'Neill DK
    Gerontology; 1988; 34(5-6):221-30. PubMed ID: 2975617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of NK-mediated natural resistance by interferon treatment of murine lymphomas.
    Greenberg AH; Miller V; Jablonski T; Pohajdak B
    J Immunol; 1984 Apr; 132(4):2129-34. PubMed ID: 6199424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.